Oncology

Mosunetuzumab-axgb (Lunsumio) displayed clinically meaningful and durable responses among a dedicated cohort of patients with previously untreated mar...

According to Jorge Cortes, MD, director, and Cecil F. Whitaker Jr., GRA Eminent Scholar Chair in Cancer of the Georgia Cancer Center, outcomes with hi...

da Silveira WA, Fazelinia H, Rosenthal SB, Laiakis EC, Kim MS, Meydan C, et al. Comprehensive multi-omics analysis reveals mitochondrial stress as a c...

Ferrari A, Chisholm JC, Jenney M, Minard-Colin V, Orbach D, Casanova M, et al. Adolescents and young adults with rhabdomyosarcoma treated in the Europ...

In the management of ccRCC following progression on first-line therapy, second-line treatment decisions are increasingly influenced by the initial reg...

In an interview with CancerNetwork® on nutrition during cancer treatment, Denise B. Reynolds, RD, discussed whether she observes deficiencies in vitam...

This case highlights the complexity of managing a patient with intermediate-risk metastatic ccRCC following progression on a first-line IO/TKI regimen...

Background Locally advanced nasopharyngeal carcinoma (LA-NPC) has a heterogeneous prognosis, with approximately one-fourth of patients experiencing po...

Download PDF The Original Article was published on 29 July 2014 Correction to: British Journal of Cancer https://doi.org/10.1038/bjc.2014.426, publish...

Nutrition is an important and often overlooked aspect of the oncology treatment paradigm that could significantly impact the health and quality of lif...